Author: Shehata, Ghaydaa A.; Lord, Kevin C.; Grudzinski, Michaela C.; Elsayed, Mohamed; Abdelnaby, Ramy; Elshabrawy, Hatem A.
Title: Neurological Complications of COVID-19: Underlying Mechanisms and Management Cord-id: old8wyr6 Document date: 2021_4_15
ID: old8wyr6
Snippet: COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss
Document: COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss of taste and smell, encephalitis, encephalopathy, and cerebrovascular diseases are the most common neurological complications that are associated with COVID-19. In addition, seizures, neuromuscular junctions’ disorders, and Guillain–Barré syndrome were reported as complications of COVID-19, as well as neurodegenerative and demyelinating disorders. However, the management of these conditions remains a challenge. In this review, we discuss the prevalence, pathogenesis, and mechanisms of these neurological sequelae that are secondary to SARS-CoV-2 infection. We aim to update neurologists and healthcare workers on the possible neurological complications associated with COVID-19 and the management of these disease conditions.
Search related documents:
Co phrase search for related documents- abnormal appearance and acute respiratory: 1, 2, 3, 4, 5
- abnormal appearance and acute respiratory syndrome: 1, 2, 3, 4, 5
- abnormal finding and acute ards respiratory distress syndrome: 1
- abnormal finding and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abnormal finding and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
- abnormal finding and lopinavir ritonavir: 1
- absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and acute ischemic stroke: 1, 2, 3, 4, 5, 6, 7
- absence presence and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and ad develop: 1
- absence presence and ad disease: 1, 2
- absence presence and ade antibody dependent enhancement: 1, 2
- absence presence and adenosine analog: 1
- absence presence and long term study: 1, 2
- absence presence and lopinavir ritonavir: 1, 2
- absence presence and lung macrophage: 1
- absence presence and lymphocyte neutrophil: 1, 2, 3, 4, 5
- absence presence and lymphocyte neutrophil ratio: 1
Co phrase search for related documents, hyperlinks ordered by date